Detalhe da pesquisa
1.
Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital.
J Oncol Pharm Pract
; 27(6): 1432-1438, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32936721
2.
Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital.
J Oncol Pharm Pract
; 26(1): 133-140, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31117914